Lifecore Biomedical, Inc. Selling, General, and Administrative Expenses (SG&A) for the Trailing 12 Months (TTM) ending February 23, 2025: USD 47.74 M

Lifecore Biomedical, Inc. Selling, General, and Administrative Expenses (SG&A) is USD 47.74 M for the Trailing 12 Months (TTM) ending February 23, 2025, a 19.57% change year over year. Selling, general, and administrative (SG&A) expenses are the expenses related to the sales and marketing efforts, as well as general and administrative functions of a company.
  • Lifecore Biomedical, Inc. Selling, General, and Administrative Expenses (SG&A) for the Trailing 12 Months (TTM) ending February 25, 2024 was USD 39.92 M, a -15.30% change year over year.
  • Lifecore Biomedical, Inc. Selling, General, and Administrative Expenses (SG&A) for the Trailing 12 Months (TTM) ending February 26, 2023 was USD 47.14 M, a -15.28% change year over year.
  • Lifecore Biomedical, Inc. Selling, General, and Administrative Expenses (SG&A) for the Trailing 12 Months (TTM) ending February 28, 2022 was USD 55.63 M, a -17.48% change year over year.
  • Lifecore Biomedical, Inc. Selling, General, and Administrative Expenses (SG&A) for the Trailing 12 Months (TTM) ending February 28, 2021 was USD 67.42 M, a -9.72% change year over year.
Key Data
Date Selling, General, and Administrative Expenses (SG&A) Research and Development (R&D) Expenses Revenue Revenue